Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

por Papadatos-Pastos, Dionysis, Yuan, Wei, Pal, Abhijit, Crespo, Mateus, Ferreira, Ana, Gurel, Bora, Prout, Toby, Ameratunga, Malaka, Chénard-Poirier, Maxime, Curcean, Andra, Bertan, Claudia, Baker, Chloe, Miranda, Susana, Masrour, Nahal, Chen, Wentin, Pereira, Rita, Figueiredo, Ines, Morilla, Ricardo, Jenkins, Ben, Zachariou, Anna, Riisnaes, Ruth, Parmar, Mona, Turner, Alison, Carreira, Suzanne, Yap, Christina, Brown, Robert, Tunariu, Nina, Banerji, Udai, Lopez, Juanita, de Bono, Johann, Minchom, Anna
Publicado 2022